<![CDATA[ Health & Pharma ]]> en Fri, 24 Apr 2026 13:47:12 UTC <![CDATA[Long-Term Data Show Taletrectinib Delivers High Response Rates in ROS1+ NSC Lung Cancer]]> https://healthandpharma.net/ibtrozi-taletrectinib-nsclc-lung-cancer ONCOLife Thu, 23 Apr 2026 21:34:42 UTC <![CDATA[FDA-Cleared Utepreva Device Aims to Improve Early Endometrial Cancer Detection]]> https://healthandpharma.net/fda-utepreva-device-endometrial-cancer-detection-test Cancer Thu, 23 Apr 2026 17:39:24 UTC <![CDATA[PLN-101095 Plus Pembrolizumab Shows Durable Responses in ICI-Refractory Solid Tumors]]> https://healthandpharma.net/pln-101095-checkpoint-inhibitor-pembrolizumab-solid-tumors ONCOLife Wed, 22 Apr 2026 23:49:46 UTC <![CDATA[Opaganib Shows Dual Preclinical Promise in Neuroblastoma and Triple- Breast Cancer]]> https://healthandpharma.net/opaganib-neuroblastoma-breast-cancer ONCOLife Wed, 22 Apr 2026 22:05:28 UTC <![CDATA[Ozekibart Plus FOLFIRI Shows Encouraging Late-Line Activity in Metastatic Colorectal Cancer]]> https://healthandpharma.net/ozekibart-folfiri-metastatic-colorectal-cancer ONCOLife Wed, 22 Apr 2026 16:38:24 UTC <![CDATA[FDA Grants Breakthrough Status to First Viral-Integration MRD Liquid Biopsy in Hepatocellular Carcinoma]]> https://healthandpharma.net/fda-breakthrough-viral-mrd-liquid-biopsy-hepatocellular-carcinoma FDA & EMA Wed, 22 Apr 2026 12:11:48 UTC <![CDATA[FDA Gives Priority Review to PADCEV Plus Pembrolizumab in Broader Perioperative MI Bladder Cancer]]> https://healthandpharma.net/fda-priority-padcev-pembrolizumab-mi-bladder-cancer FDA & EMA Mon, 20 Apr 2026 23:48:08 UTC <![CDATA[AACR 2026 Data Show Multi-Biomarker MCED Approach Improves Early Cancer Detection]]> https://healthandpharma.net/aacr2026-abbott-biomarker-mced-cancer-detection ONCOLife Sat, 18 Apr 2026 15:19:35 UTC <![CDATA[FDA Grants Breakthrough Designation to First Urine-Based Multi-Cancer Early Detection Test]]> https://healthandpharma.net/fda-breakthrough-urine-cancer-detection-test-toby ONCOLife Fri, 17 Apr 2026 20:57:59 UTC <![CDATA[Daraxonrasib Doubles Overall Survival in Previously Treated Metastatic Pancreatic Cancer]]> https://healthandpharma.net/daraxonrasib-metastatic-pancreatic-cancer ONCOLife Thu, 16 Apr 2026 00:00:55 UTC <![CDATA[AI Nodule Detection Helps Sarasota Memorial Reach 75% Early Lung Cancer Diagnosis]]> https://healthandpharma.net/ai-nodule-detection-sarasota-memorial-lung-cancer AI Wed, 15 Apr 2026 21:05:54 UTC <![CDATA[Illumina Launch 100 K Genome Effort to Advance Cancer and Rare Disease Research]]> https://healthandpharma.net/illumina-d3b-genome-pediatric-cancer-rare-disease AI Wed, 15 Apr 2026 14:59:41 UTC <![CDATA[Zenocutuzumab Gains NCCN Support as FDA Review Advances in Cholangiocarcinoma]]> https://healthandpharma.net/bizengri-zenocutuzumab-fda-bla-cholangiocarcinoma FDA & EMA Wed, 15 Apr 2026 13:56:21 UTC <![CDATA[Phase 2 Data Position Trastuzumab Pamirtecan as a Promising Option in Endometrial Cancer]]> https://healthandpharma.net/biontech-trastuzumab-pamirtecan-her2-endometrial-cancer ONCOLife Tue, 14 Apr 2026 13:34:16 UTC <![CDATA[Mocertatug Rezetecan Shows Strong Responses in Ovarian and Endometrial Cancers]]> https://healthandpharma.net/gsk-mocertatug-rezetecan-ovarian-endometrial-cancers FDA & EMA Mon, 13 Apr 2026 20:32:51 UTC <![CDATA[FDA Grants Priority Review to Ifinatamab Deruxtecan in Pretreated ES-SC Lung Cancer]]> https://healthandpharma.net/fda-ifinatamab-deruxtecan-essc-lung-cancer FDA & EMA Mon, 13 Apr 2026 18:48:06 UTC <![CDATA[MD Anderson Study Identifies DPY30 as Therapeutic Target in Pancreatic Cancer]]> https://healthandpharma.net/md-anderson-dyp30-biomarker-target-pancreatic-cancer ONCOLife Mon, 13 Apr 2026 16:14:28 UTC <![CDATA[Blocking DHODH Helps Triple Combination Overcome Resistance in Lung Cancer]]> https://healthandpharma.net/dhodh-radiotherapy-lung-cancer-ferroptosis-leflunomide ONCOLife Sat, 11 Apr 2026 21:55:16 UTC <![CDATA[New Strategy Blocks NMD, Unmasks Hidden Tumor Antigens, and Boosts Immunotherapy]]> https://healthandpharma.net/blocks-nmd-hidden-tumor-immunotherapy-cancer ONCOLife Sat, 11 Apr 2026 16:43:09 UTC <![CDATA[Neladalkib Reaches FDA Review for TKI-Pretreated ALK+ Non-Small Cell Lung Cancer]]> https://healthandpharma.net/neladalkib-fda-alk-nsclc-lung-cancer FDA & EMA Fri, 10 Apr 2026 21:16:04 UTC <![CDATA[New B7-H3 Radio-Theranostic Promises to Broaden Targeted Radiation Across Solid Tumors]]> https://healthandpharma.net/betabart-radiotheranostic-radiation-olid-tumors ONCOLife Sun, 05 Apr 2026 16:46:43 UTC <![CDATA[FDA Grants Breakthrough Status to WU-CART-007 for T-Cell Leukemias and Lymphomas]]> https://healthandpharma.net/fda-breakthrough-wu-cart-tcell-leukemias-lymphomas FDA & EMA Fri, 03 Apr 2026 22:47:16 UTC <![CDATA[New IHC Biomarker Test Predicts Which Gastric Cancer Patients Benefit from Immunotherapy]]> https://healthandpharma.net/ihc-biomarker-test-predict-gastric-cancer-immunotherapy ONCOLife Wed, 01 Apr 2026 14:32:12 UTC <![CDATA[Nonviral Gene Delivery Platform Offers Promise for Cancer Treatment and Cell Therapy]]> https://healthandpharma.net/nanoparticle-nonviral-gene-therapy-promise-cancer ONCOLife Mon, 30 Mar 2026 22:52:11 UTC <![CDATA[Immunotherapy Boosts Chemo Cutting Recurrence Risk by 50% in Colon Cancer]]> https://healthandpharma.net/immunotherapy-atezolizumab-boosts-chemotherapy-dmmr-colon-cancer ONCOLife Mon, 30 Mar 2026 16:25:50 UTC <![CDATA[AI Predicts Chemotherapy Benefit in Breast Cancer Using Routine Pathology Slides]]> https://healthandpharma.net/ai-predict-chemotherapy-breast-cancer-pathology Clinical Trials Mon, 30 Mar 2026 15:06:02 UTC <![CDATA[FDA Approves Agilent’s PD-L1 Test to Guide KEYTRUDA Use in Esophageal and GEJ Carcinoma]]> https://healthandpharma.net/fda-approves-agilent-pd-l1-test-keytruda-esophageal-gej-carcinoma FDA & EMA Sun, 29 Mar 2026 16:35:58 UTC <![CDATA[Light-Activated Copper Nanoparticles Trigger Cuproptosis in Drug-Resistant Cancer Cells]]> https://healthandpharma.net/photoresponsive-copper-nanoparticles-cuproptosis-cancer ONCOLife Sat, 28 Mar 2026 23:08:14 UTC <![CDATA[New Protein Modification Linked to IDH-Mutant Cancers Opens Therapeutic Possibilities]]> https://healthandpharma.net/protein-modification-idh-mutant-cancers-therapeutic ONCOLife Thu, 26 Mar 2026 22:37:49 UTC <![CDATA[BioNTech Showcases Promising Bispecific and ADC Data in Lung Cancer at ELCC 2026]]> https://healthandpharma.net/biontech-bispecific-adc-lung-cancer-elcc2026 ONCOLife Thu, 26 Mar 2026 17:06:00 UTC <![CDATA[Sunvozertinib Outperforms Chemo in First-Line EGFR Exon 20 Insertion NSC Lung Cancer]]> https://healthandpharma.net/sunvozertinib-chemotherapy-egfr-nsclc-lung-cancer ONCOLife Tue, 24 Mar 2026 01:55:30 UTC <![CDATA[Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors]]> https://healthandpharma.net/magnetic-nanoparticle-hyperthermia-cancer-solid-tumors ONCOLife Mon, 23 Mar 2026 22:21:12 UTC <![CDATA[TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis]]> https://healthandpharma.net/tg-therapeutics-briumvi-multiple-sclerosis Biotech Sun, 22 Mar 2026 18:45:54 UTC <![CDATA[Targeted Bladder Cancer Therapy Erda-iDRS Achieves 89% Response Rate and PDC]]> https://healthandpharma.net/bladder-cancer-erda-idrsr-response-rate-erdafitinib ONCOLife Sun, 22 Mar 2026 15:08:25 UTC <![CDATA[Atirmociclib Reduces Progression Risk by 40% in CDK4/6 Metastatic Breast Cancer]]> https://healthandpharma.net/atirmociclib-cdk4-metastatic-breast-cancer ONCOLife Sat, 21 Mar 2026 20:26:29 UTC <![CDATA[TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer]]> https://healthandpharma.net/talazoparib-enzalutamide-prostate-cancer-mCSPC ONCOLife Sat, 21 Mar 2026 17:42:03 UTC <![CDATA[FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma]]> https://healthandpharma.net/fda-approves-nivolumab-opdivo-immunotherapy-hodgkin-lymphoma FDA & EMA Fri, 20 Mar 2026 23:03:32 UTC <![CDATA[Abenacianine Enters Phase 3 to Enhance Real-Time Tumor Detection in Lung Surgery]]> https://healthandpharma.net/abenacianine-tumor-lung-cancer-surgery-vergent-bioscience ONCOLife Fri, 20 Mar 2026 16:37:27 UTC <![CDATA[CellCarta Secures Global Exclusivity for Aspyre Lung to Advance Lung Cancer Testing]]> https://healthandpharma.net/cellcarta-biofidelity-aspyre-test-lung-cancer Cancer Thu, 19 Mar 2026 23:40:11 UTC <![CDATA[Reengineering CAR-T Cells to Last Longer in the Fight Against Cancer and HIV]]> https://healthandpharma.net/car-tcell-longer-fight-against-cancer-hiv 50% vs <5%), demonstrating enhanced persistence, stronger recall responses]]> ONCOLife Tue, 17 Mar 2026 21:33:04 UTC